A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Measuring Intestinal Barrier Permeability by Detecting Flux of Fluorescent Tracers Across Human Colonoid Monolayers

1K views

⸱

DOI:

10.3791/68857

⸱

October 17th, 2025

In This Article

Summary

We describe a technique for measuring intestinal barrier integrity, whereby the rate of translocation of a fluorescently-tagged sugar of known size reflects the permeability of tissue-derived human intestinal colonoids.

Abstract

The intestinal barrier is a critical site of regulation between luminal antigens and the host immune system, and its dysregulation is implicated in multiple gastrointestinal diseases. Intestinal organoids can be a useful tool to understand and model differences in intestinal barrier integrity. Here, we describe a protocol that uses human colonoids to quantify functional intestinal barrier differences by measuring the flux of fluorescent tracers across organoid monolayers. After growing monolayers to confluence, we add a fluorescent tracer, such as FITC-dextran, to the apical chamber and detect its translocation into the basolateral chamber over time. Increased translocation of the fluorescent tracer is reflective of a more permeable, or weaker, epithelial barrier. This protocol is an adaptable platform that allows evaluation of functional intestinal barrier differences across multiple conditions in parallel. Using variations of this protocol, one can assess transepithelial permeability to molecules of various size, shape, and chemical structure, as well as permeability differences in the context of isolated treatments or microenvironmental changes on the apical or basolateral sides of epithelial cells. This allows for a deeper understanding of the mechanism and treatment of barrier disruption in disease states.

Introduction

The intestinal mucosa is a complex structure that plays an important role in regulating the contact between the metabolites, antigens, and microbes in the intestinal lumen and the immune system and enteric circulation. Intestinal epithelial cells are a key component of this system, and in healthy conditions, form a highly selective barrier. Transport across the epithelium can occur through multiple mechanisms: transcellular active or passive transport, paracellular pore or leak pathways regulated by tight junctions and adherens junctions. Whether any of these pathways can be used by a molecule to translocate across the epithelium is determined by the hydrophobicity, s....

Access restricted. Please log in or start a trial to view this content.

Protocol

All samples were acquired and used in accordance with a protocol approved by the University of Colorado Institutional Review Board (IRB), protocol number 14-2012.

NOTE: All procedures in steps 1-3 should be done in a sterile biosafety cabinet with sterile technique. A schematic of the protocol is presented in Figure 1.

1. Establishment of human colonoids from frozen cultures

NOTE: Ensure all materials are ready in the biosafety cabinet before thawing cells to minimize exposure of thawed organoids to freezing medium. The protocol begins with ....

Access restricted. Please log in or start a trial to view this content.

Results

Using this protocol, the permeability of healthy human colonoids in the presence and absence of inflammatory signaling was analyzed. Addition of a mixture of inflammatory cytokines, termed cytomix, which includes IFNγ, TNFα, and IL-1β (each at 10 ng/ml), has been previously shown to induce intestinal barrier dysfunction as measured by TEER in intestinal epithelial cell models20,27. We aimed to determine if this barrier dysfunction could be recapitulated using the.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This is a protocol to assess the intestinal barrier in the physiologically representative model of human colonoid monolayers. The fluorescent tracer flux assay described here provides information about the functional integrity of the barrier beyond what is gleaned with other types of barrier assays, such as TEER, Ussing chamber measurements, or evaluation of tight junction protein expression. Additionally, the use of patient-derived intestinal organoid models confers the benefit of recapitulating complex human physiology.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

There are no disclosures or conflicts of interest.

Acknowledgements

Dr. Sean Colgan is funded by NIH grants DK1047893, DK50189, DK095491, DK103639, and VA Merit BX002182.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
15 mL conical centrifuge tubesCelltreat229411
2 mL Internal Threaded Cryogenic Vial Corning430488
50 mL conical centrifuge tubesCelltreat229421
6-well plate, tissue culture treatedCelltreat229106
70 μm cell strainerFalcon352350
96-well black/clear bottom plateThermo Scientific165305
A83-01 R&D2939
BioTek Synergy plate readerAgilentSynergy H1
Cellometer Auto T4 Brightfield cell counterNexcelcomCMT-AT4P
Cellometer cell counting chambersNexcelcomNC1531583
CHIR99021Sigma-AldrichSML1046-5MG
Collagen coating solution Cell Applications125-50
DMEM/F-12Gibco11330057
DMSOSigma-AldrichD2650-100ML
Ethanol 100%Fisher ScientificA4094
EVOM2 Voltohm Meter with Stx2 ElectrodeWorld Precision InstrumentsNC9792051
Fetal Bovine Serum (FBS)CytivaSH30396.03HI
Filter pipet tipsFisher Scientific02-707-000, 02-707-002, 02-707-006, 02-707-008
Fluorescein isothiocyanate (FITC)-dextran, 4kDaSigma-Aldrich46944
Gastrin I (Human)R&D3006
GlutaMAX Fisher Scientific35050061200 mM L-alanyl-L-glutamine dipeptide
Hanks buffered saline solution 10xThermo Scientific14065056
HEPES 1MThermo Scientific15630080
Interferon gamma recombinant humanBioLegend575308
Interleukin 1 beta recombinant humanThermo scientific200-01B-500UG
IntestiCult Intestinal Organoid Growth Medium (Human)STEMCELL Technologies06010 Commercial intestinal organoid media
Live inverted microscopeOlympusIX85
MatrigelCorning354234Extracellular matrix (ECM)
Microbiological incubatorFisher Scientific151030515
Multiwell plate for suspension culture, 24 wellGreiner Bio-one662102
NicotinamideR&D4106
ParafilmMillipore SigmaHS234526BSealing film
Pasteur pipets (borosilicate glass)Fisher Scientific13-678-20B
PBS Gibco10010-023
Penicillin Streptomycin (10,000 U/mL)Gibco15140122
Recombinant moouse epidermal growth factorR&D2028-EG
Refrigerated centrifugeBeckman CoulterBE-AX15R
SB202190 R&D1264
ThiazovivinR&D3845
ThinCert cell culture insert for 24 well plate, 0.4 μmGreiner Bio-one662641
Trypsin-EDTA (0.25%)Fisher Scientific25200114
Tumor necrosis factor alpha recombinant humanR&D10291-TA-100
Y-27632 dihydrochloride TocrisTB1254-GMP

References

  1. Vanuytsel, T., Tack, J., Farre, R. The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation. Front Nutr. 8, 717925(2021).
  2. Tsai, P. Y., et al. Il-22 upregulates epithelial claud....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Intestinal OrganoidsFITC-DextranTransepithelial PermeabilityEpithelial BarrierBarrier IntegrityOrganoid Model